£26.0M
The life sciences software provider raised the capital from Horizons Ventures and Sofinnova Partners to fund commercial growth.
Synthace provides a cloud platform that enables life scientists to automate experiments and share insights.
Synthace operates a cloud platform that helps life sciences organisations automate biology experimentation and share insights. Seven of the top ten global pharmaceutical companies use its software.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Synthace's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Guy Levy-Yurista
CEO
The life sciences software provider raised the capital from Horizons Ventures and Sofinnova Partners to fund commercial growth.